MRC cleared of financial blunders

Government rejects claims that MRC mismanaged funds, but MPs won't let matter lie

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The UK government has rejected claims that the Medical Research Council (MRC) is guilty of financial bungling by misjudging its projected income and then having to turn down applications for research grants.

The Department of Trade and Industry (DTI) cleared the UK's leading medical research institution of mismanagement in its official response to a damning report from the House of Commons Science and Technology Committee. The response was delivered Wednesday, June 4, in the House of Commons and prompted an angry response from some MPs.

Although the DTI agreed the MRC needed to improve the way it makes financial judgements and "plan its forward expenditure in detail," it rejected allegations that this amounted to mismanagement.

In a detailed response to the committee's criticisms it stated, "We cannot agree with the committee's assertion that the MRC has mismanaged its funds. We are satisfied it has properly controlled its expenditure. Its accounts ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Pat Hagan

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours